[go: up one dir, main page]

PT3565551T - Métodos de tratamento de infeções bacterianas com uma combinação de vaborbactam e meropenem - Google Patents

Métodos de tratamento de infeções bacterianas com uma combinação de vaborbactam e meropenem

Info

Publication number
PT3565551T
PT3565551T PT187358130T PT18735813T PT3565551T PT 3565551 T PT3565551 T PT 3565551T PT 187358130 T PT187358130 T PT 187358130T PT 18735813 T PT18735813 T PT 18735813T PT 3565551 T PT3565551 T PT 3565551T
Authority
PT
Portugal
Prior art keywords
methods
bacterial infections
treating bacterial
treating
infections
Prior art date
Application number
PT187358130T
Other languages
English (en)
Original Assignee
Melinta Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=62791302&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT3565551(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Melinta Therapeutics Inc filed Critical Melinta Therapeutics Inc
Publication of PT3565551T publication Critical patent/PT3565551T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/69Boron compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT187358130T 2017-01-09 2018-01-08 Métodos de tratamento de infeções bacterianas com uma combinação de vaborbactam e meropenem PT3565551T (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762444238P 2017-01-09 2017-01-09
US201762513936P 2017-06-01 2017-06-01

Publications (1)

Publication Number Publication Date
PT3565551T true PT3565551T (pt) 2024-06-14

Family

ID=62791302

Family Applications (1)

Application Number Title Priority Date Filing Date
PT187358130T PT3565551T (pt) 2017-01-09 2018-01-08 Métodos de tratamento de infeções bacterianas com uma combinação de vaborbactam e meropenem

Country Status (21)

Country Link
US (1) US12478606B2 (pt)
EP (2) EP3565551B1 (pt)
JP (2) JP7436206B2 (pt)
KR (2) KR102768209B1 (pt)
CN (1) CN110402139A (pt)
AU (1) AU2018205327B2 (pt)
BR (1) BR112019014089A2 (pt)
CA (1) CA3048650A1 (pt)
CL (2) CL2019001918A1 (pt)
CO (1) CO2019008575A2 (pt)
DK (1) DK3565551T3 (pt)
ES (1) ES2979266T3 (pt)
FI (1) FI3565551T3 (pt)
HU (1) HUE066805T2 (pt)
MX (2) MX390529B (pt)
NZ (1) NZ755141A (pt)
PH (1) PH12019501606A1 (pt)
PL (1) PL3565551T3 (pt)
PT (1) PT3565551T (pt)
SG (1) SG11201906226YA (pt)
WO (1) WO2018129479A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3048650A1 (en) 2017-01-09 2018-07-12 Rempex Pharmaceuticals, Inc. Methods of treating bacterial infections
KR20200066664A (ko) 2017-10-03 2020-06-10 멜린타 테라퓨틱스, 인크. 세균 감염증을 치료하는 방법
US20230230698A1 (en) * 2020-07-27 2023-07-20 Northwestern University Antimicrobial choice algorithm for urinary tract infections
WO2024018372A2 (en) * 2022-07-20 2024-01-25 Sri Sathya Sai Institute Of Higher Learning A machine learning platform for predicting uropathogens and their resistance for prescribing suitable urinary infection therapy
WO2024228130A1 (en) * 2023-05-02 2024-11-07 Cipla Limited Pharmaceutical combinations and compositions thereof comprising antibacterial agents

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783443A (en) 1986-03-03 1988-11-08 The University Of Chicago Amino acyl cephalosporin derivatives
FR2936951B1 (fr) 2008-10-10 2010-12-03 Novexel Nouvelles combinaisons de composes heterocycliques azotes antibacteriens avec d'autres composes antibacteriens et leur utilisation comme medicaments
RU2599791C2 (ru) 2010-08-10 2016-10-20 Ремпекс Фармасьютикэлз, Инч. Циклические бороновые кислотно-эфирные производные и их использование в терапии
US10561675B2 (en) 2012-06-06 2020-02-18 Rempex Pharmaceuticals, Inc. Cyclic boronic acid ester derivatives and therapeutic uses thereof
US9103386B2 (en) * 2013-05-15 2015-08-11 Schaeffler Technologies AG & Co. KG Reduced drag clutch plate
CN107530364A (zh) 2015-04-24 2018-01-02 莱姆派克斯制药公司 治疗细菌感染的方法
US9949995B2 (en) 2015-09-04 2018-04-24 Case Western Reserve University Compositions and methods of treating of bacterial infections with β-lactamase inhibitors
CA3048650A1 (en) 2017-01-09 2018-07-12 Rempex Pharmaceuticals, Inc. Methods of treating bacterial infections

Also Published As

Publication number Publication date
BR112019014089A2 (pt) 2020-02-04
JP7436206B2 (ja) 2024-02-21
NZ755141A (en) 2023-01-27
CN110402139A (zh) 2019-11-01
WO2018129479A1 (en) 2018-07-12
US12478606B2 (en) 2025-11-25
EP3565551A1 (en) 2019-11-13
PH12019501606A1 (en) 2020-06-15
CL2020001886A1 (es) 2020-12-18
JP2020504154A (ja) 2020-02-06
FI3565551T3 (fi) 2024-06-18
EP3565551B1 (en) 2024-03-20
KR20240133785A (ko) 2024-09-04
AU2018205327B2 (en) 2023-11-30
DK3565551T3 (da) 2024-06-17
CA3048650A1 (en) 2018-07-12
ES2979266T3 (es) 2024-09-25
JP2023012538A (ja) 2023-01-25
US20190336475A1 (en) 2019-11-07
HUE066805T2 (hu) 2024-09-28
MX390529B (es) 2025-03-20
AU2018205327A1 (en) 2019-07-25
MX2022001704A (es) 2022-03-11
CO2019008575A2 (es) 2019-08-30
PL3565551T3 (pl) 2024-09-23
KR102768209B1 (ko) 2025-02-18
KR20190104385A (ko) 2019-09-09
EP3565551A4 (en) 2020-09-23
CL2019001918A1 (es) 2020-02-14
EP4212157A1 (en) 2023-07-19
MX2019008281A (es) 2019-12-02
SG11201906226YA (en) 2019-08-27

Similar Documents

Publication Publication Date Title
GB2554629B8 (en) Prevention and treatment of microbial infections
SG11201702688UA (en) Methods of treating rsv infections
SG11201700621XA (en) Antibiotic compositions for treating bacterial infections
ZA201703245B (en) Combination therapy for treatment of resistant bacterial infections
DK3630111T3 (en) Compounds and methods for treating bacterial infections
PT3565551T (pt) Métodos de tratamento de infeções bacterianas com uma combinação de vaborbactam e meropenem
PT3285787T (pt) Tratamento de infeções bacterianas em aquicultura
EP3190893A4 (en) Compositions and methods for treating and preventing bacterial infections
PT3856213T (pt) Métodos de tratamento de infeções utilizando bactérias
IL260952B (en) Preparations and methods for treating infections
IL256236B (en) Mannose derivatives for the treatment of bacterial infections
SG11202003009QA (en) Methods of treating bacterial infections
GB2558090B (en) Prevention and treatment for microbial infections
HK40036490A (en) Methods of treating bacterial infections
HK40000701A (en) New method of treating bacterial infections
HK40026676A (en) Compounds and methods for treating bacterial infections
GB201721022D0 (en) Detection of bacterial infections
GB201619704D0 (en) Treatment of pathogenic infections
GB201517300D0 (en) Dectection of bacterial infections
GB201519483D0 (en) Prevention and treatment of microbial infections
GB201518252D0 (en) Prevention and treatment of microbial infections
GB201513047D0 (en) Prevention and treatment of microbial infections
GB201511576D0 (en) Prevention and treatment of microbial infections
HK1261426A1 (en) Hydroxypyridinone and hydroxypyrimidinone based compounds for treating bacterial infections
GB201509654D0 (en) Prevention and treatment of microbial infections